MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-15-2023
Invacare Corporation Net Income 2011-2026 | IVC
Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.
Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]
It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.
The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.
Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.
It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.
However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.
Annual Net Income Invacare Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -20.6 M | 1.94 M | -28.3 M | -53.3 M | -43.9 M | -76.5 M | -42.9 M | -26.2 M | -56.1 M | 33.1 M | 1.83 M | -4.11 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 33.1 M | -76.5 M | -26.3 M |
Quarterly Net Income Invacare Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -41.2 M | - | -34.4 M | -21.9 M | -24.2 M | 1.94 M | -22.8 M | -10.7 M | -14 M | -5.12 M | -7.28 M | -16.6 M | -16.6 M | -18.7 M | -8.04 M | -12.7 M | -13.9 M | -1.24 M | -12 M | -16.5 M | -14.1 M | -17.7 M | -18.6 M | -23.5 M | -16.8 M | -17.6 M | -5.02 M | -11.6 M | -8.62 M | -2.93 M | -7.79 M | -8.22 M | -7.25 M | -9.38 M | -15.1 M | -13.6 M | -18 M | -5.77 M | 16.1 M | -12.5 M | 35.2 M | -7.29 M | 2.86 M | -1.98 M | 8.23 M | -35 M | 12.8 M | 10.7 M | 7.45 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 35.2 M | -41.2 M | -10 M |
References
- Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.
Net Income of other stocks in the Medical devices industry
| Issuer | Net Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
-143 M | $ 11.69 | -3.79 % | $ 1.75 B |  USA |
 |
Butterfly Network
BFLY
|
-72.5 M | $ 4.22 | 0.6 % | $ 893 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-18.6 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-59.7 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
53.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-81.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.94 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-12.3 M | - | -5.86 % | $ 30.6 M | USA |
 |
BioSig Technologies
BSGM
|
-10.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
-50.5 M | - | - | $ 16.4 M | USA |
 |
Inogen
INGN
|
-22.7 M | $ 6.22 | -3.57 % | $ 165 M | USA |
 |
Cardiovascular Systems
CSII
|
-36.9 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
-9.57 M | $ 1.36 | 0.37 % | $ 21.9 M | USA |
 |
Integer Holdings Corporation
ITGR
|
103 M | $ 84.52 | -0.96 % | $ 2.94 B | USA |
 |
Apollo Endosurgery
APEN
|
-39.8 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-18.3 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
-16.7 M | - | -4.14 % | $ 702 M | USA |
 |
AxoGen
AXGN
|
-15.7 M | $ 31.8 | 0.14 % | $ 1.46 B | USA |
 |
CONMED Corporation
CNMD
|
47.1 M | $ 36.27 | -0.98 % | $ 1.13 B | USA |
 |
LivaNova PLC
LIVN
|
-242 M | $ 62.84 | -0.63 % | $ 3.43 B |  Britain |
 |
Soliton, Inc.
SOLY
|
-14.5 M | - | -1.42 % | $ 435 M | USA |
 |
LENSAR
LNSR
|
-31.4 M | $ 5.92 | -2.47 % | $ 68.2 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-10.9 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Electromed
ELMD
|
7.54 M | $ 24.12 | -1.51 % | $ 204 M | USA |
 |
Misonix, Inc.
MSON
|
-17.4 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-24.9 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
-72.3 M | - | - | $ 955 M | USA |
 |
Medtronic PLC
MDT
|
4.66 B | $ 87.16 | -0.06 % | $ 112 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-20.7 M | $ 0.67 | -0.53 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
-13.4 M | $ 2.24 | -2.61 % | $ 3.5 M | USA |
 |
BIOLASE
BIOL
|
-20.6 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
-70.8 M | $ 10.91 | 5.21 % | $ 1.47 B | USA |
 |
Myomo
MYO
|
-15.6 M | $ 0.71 | 0.94 % | $ 29.7 M | USA |
 |
IRadimed Corporation
IRMD
|
22.5 M | $ 99.21 | 0.01 % | $ 1.26 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-53.5 M | $ 2.36 | -3.48 % | $ 138 M | Israel |
 |
EDAP TMS S.A.
EDAP
|
-19 M | $ 3.81 | 2.14 % | $ 142 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
-39.6 M | $ 16.28 | -1.15 % | $ 382 M | USA |
 |
Orthofix Medical
OFIX
|
-92.2 M | $ 11.8 | -0.59 % | $ 467 M |  Curacao |
 |
Outset Medical
OM
|
-81.7 M | $ 3.47 | -4.15 % | $ 52.8 K | USA |
 |
Inspire Medical Systems
INSP
|
145 M | $ 51.34 | -1.67 % | $ 1.51 B | USA |
 |
Penumbra
PEN
|
178 M | $ 334.62 | -0.29 % | $ 13 B | USA |
 |
Pulmonx Corporation
LUNG
|
-54 M | $ 1.39 | -0.36 % | $ 56.6 M | USA |
 |
Cutera
CUTR
|
-57.2 M | - | -10.19 % | $ 1.99 M | USA |
 |
Insulet Corporation
PODD
|
247 M | $ 225.08 | -0.88 % | $ 15.8 B | USA |
 |
Profound Medical Corp.
PROF
|
-30.7 M | $ 5.22 | -3.33 % | $ 180 M | Canada |
 |
Dynatronics Corporation
DYNT
|
-10.9 M | - | 14.99 % | $ 929 K | USA |